Suppuration
Suppuration
Explore linked clinical trials. Standard reference: MESH:M0020847152 results · Page 1 of 7
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 2 | 2026-10-09 | NCT07213973 | |
| Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 1 | 2026-10-09 | NCT07049575 | |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 3 | 2026-10-09 | NCT06855498 | |
| Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis | Abdominal Abscess, Infections, Suppuration, abscess | Recruiting | Phase 3 | 2026-10-09 | NCT06841003 | |
| Evaluating Antibiotic Course Upon Adequate Treatment of Empyema | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Suppuration, empyema, pleural disorder, pleural empyema, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not applicable | 2026-10-07 | NCT07862361 | |
| Perspectives on Antibiotics and Tracking Symptoms in Children | Bacterial Infections and Mycoses, Ear Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Skin and Connective Tissue Diseases, Staphylococcal Skin Infections, Stomatognathic Diseases, Suppuration, Urogenital Diseases, bacterial infectious disease, cellulitis, connective tissue disorder, gram-positive bacterial infections, impetigo, otitis media, otorhinolaryngologic disease, pharyngitis, respiratory system disorder, respiratory tract infectious disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, staphylococcal infection, streptococcal infection, tonsillitis, urinary system disorder, urinary tract infection | Recruiting | Not applicable | 2026-10-07 | NCT07093749 | |
| A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Not yet recruiting | Phase 1 | 2026-10-02 | NCT07855276 | |
| Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012) | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Active, not recruiting | Phase 2 | 2026-10-02 | NCT06956235 | |
| A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-10-01 | NCT07287644 | |
| Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis | Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, Suppuration, atopic eczema, bacterial infectious disease, cellulitis, connective tissue disorder, dermatitis, gram-positive bacterial infections, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder, skin disorder caused by infection, staphylococcal infection | Recruiting | Not applicable | 2026-09-30 | NCT07333378 | |
| Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pleural Effusion, Suppuration, empyema, pleural disorder, pleural empyema, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 4 | 2026-09-29 | NCT07095361 | |
| An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 3 | 2026-09-28 | NCT07665437 | |
| Global Healthcare Study on Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Not stated | 2026-09-28 | NCT07659769 | |
| A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT06921850 | |
| ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 2 | 2026-09-24 | NCT07783542 | |
| Abdominal aBscess Catheter Sclerotherapy (ABCS) | Abdominal Abscess, Infections, Suppuration, abscess | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-24 | NCT06906029 | |
| Does Adding a Fascial Layer to the Cartilage in Tympanoplasty for Large Tympanic Membrane Perforation Affect the Overall Results? | Ear Diseases, Infections, Suppuration, Tympanic Membrane Perforation, chronic purulent otitis media, injury, otitis media, otorhinolaryngologic disease, suppurative otitis media | Not yet recruiting | Not applicable | 2026-09-22 | NCT07834892 | |
| Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 1 | 2026-09-22 | NCT07828860 | |
| A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 2 | 2026-09-22 | NCT07225569 | |
| Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity | Bacterial Infections and Mycoses, Body Weight, Body Weight Changes, Infections, Inflammation, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, Suppuration, Weight Loss, abscess, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, nutritional disorder, obesity disorder, overnutrition, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Not yet recruiting | Phase 2 | 2026-09-21 | NCT07830329 | |
| A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Not yet recruiting | Not stated | 2026-09-21 | NCT07454889 | |
| Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections (EPHICACI) | Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, bronchial disorder, bronchiectasis, cystic fibrosis, disease, hereditary disease, hidradenitis, hidradenitis suppurativa, lung disorder, pancreas disorder, respiratory system disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Not stated | 2026-09-21 | NCT06368388 | |
| Regulation of Inflammatory Genes in Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Not stated | 2026-09-21 | NCT05507125 | |
| A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) | Axial Spondyloarthritis, Bacterial Infections and Mycoses, Infections, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, Suppuration, ankylosis, arthritic joint disease, arthropathy, bacterial infectious disease, bone disorder, hidradenitis, hidradenitis suppurativa, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, spondylitis, sweat gland disorder, vertebral column disorder | Recruiting | Phase 1 | 2026-09-18 | NCT06888193 | |
| Efficacy of Diloxanide Furoate as Additional Luminal Agent Along With Metronidazole for the Treatment of Amoebic Liver Abscess | Abdominal Abscess, Digestive System Diseases, Infections, Liver Abscess, Liver Abscess, Amebic, Liver Diseases, Parasitic, Suppuration, abscess, amebiasis, liver disorder, parasitic infectious disease, protozoa infectious disease | Not yet recruiting | Phase 3 | 2026-09-10 | NCT07807150 |